Latest news
FDA approves first interchangeable ranibizumab biosimilar Ranluspec - Generics and Biosimilars InitiativeGenerics and Biosimilars Initiative · Sat, 08 Aug 2026 20:20:14 GMTSanofi Pauses Phase 2 Trial of Monoclonal Antibody SAR445399 in Chronic Lung Disease - BioPharm InternationalBioPharm International · Thu, 06 Aug 2026 15:59:10 GMTTonix Plans Two-Dose Antibody Study; Protection Expected in 2 Days - Stock TitanStock Titan · Mon, 03 Aug 2026 11:00:00 GMTFIGURE 1. - Journal of Nuclear MedicineJournal of Nuclear Medicine · Sat, 01 Aug 2026 07:00:00 GMT